Therapeutic Isolated Limb Perfusion (ILP) in the Management of Patients With Advanced or Recurrent Limb Melanoma

Irish Journal of Medical Science - United Kingdom
doi 10.1007/s11845-011-0764-7
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Melphalan Tissue Concentrations in Patients Treated With Regional Isolated Perfusion for Melanoma of the Lower Limb

British Journal of Cancer
Cancer ResearchOncology
1994English

The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients With In-Transit Melanoma Metastases Treated With Isolated Limb Perfusion

Annals of Surgical Oncology
OncologySurgery
2018English

Isolated Limb Perfusion for Malignant Melanoma: Systematic Review on Effectiveness and Safety

Oncologist
Cancer ResearchMedicineOncology
2010English

Review of Regional Limb Perfusion With Melphalan for Malignant Melanoma

BMJ
1966English

Erratum To: Health-Related Quality of Life for Patients Who Have In-Transit Melanoma Metastases Treated With Isolated Limb Perfusion

Annals of Surgical Oncology
OncologySurgery
2016English

360. Enhanced Alpha-1 Antitrypsin (AAT) Expression and Decrease Immune Response With Isolated Limb Perfusion (ILP) Delivery of rAAV1-CB-hAAT

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis

Advances in Therapy
MedicinePharmacology
2016English

Quality of Life After Isolated Limb Infusion for In-Transit Melanoma of the Extremity

Annals of Surgical Oncology
OncologySurgery
2014English

Laparoscopic Hyperthermic Isolated Limb Perfusion a New Minimally Invasive Approach for HILP

International Journal of Hyperthermia
MedicineCancer ResearchRadiologicalPhysiologyUltrasound Technology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy